GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Huakang Biomedical Holdings Co Ltd (HKSE:08622) » Definitions » PB Ratio

Huakang Biomedical Holdings Co (HKSE:08622) PB Ratio : 0.74 (As of Jun. 25, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Huakang Biomedical Holdings Co PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-06-25), Huakang Biomedical Holdings Co's share price is HK$0.098. Huakang Biomedical Holdings Co's Book Value per Share for the quarter that ended in Dec. 2023 was HK$0.13. Hence, Huakang Biomedical Holdings Co's PB Ratio of today is 0.74.

The historical rank and industry rank for Huakang Biomedical Holdings Co's PB Ratio or its related term are showing as below:

HKSE:08622' s PB Ratio Range Over the Past 10 Years
Min: 0.51   Med: 1   Max: 2.18
Current: 0.75

During the past 9 years, Huakang Biomedical Holdings Co's highest PB Ratio was 2.18. The lowest was 0.51. And the median was 1.00.

HKSE:08622's PB Ratio is ranked better than
86.83% of 957 companies
in the Drug Manufacturers industry
Industry Median: 1.87 vs HKSE:08622: 0.75

During the past 12 months, Huakang Biomedical Holdings Co's average Book Value Per Share Growth Rate was -12.50% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -10.10% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -8.00% per year.

During the past 9 years, the highest 3-Year average Book Value Per Share Growth Rate of Huakang Biomedical Holdings Co was 62.60% per year. The lowest was -10.10% per year. And the median was 6.90% per year.

Back to Basics: PB Ratio


Huakang Biomedical Holdings Co PB Ratio Historical Data

The historical data trend for Huakang Biomedical Holdings Co's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Huakang Biomedical Holdings Co PB Ratio Chart

Huakang Biomedical Holdings Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only 0.71 0.58 1.40 1.22 0.80

Huakang Biomedical Holdings Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.22 - 1.33 - 0.80

Competitive Comparison of Huakang Biomedical Holdings Co's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Huakang Biomedical Holdings Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Huakang Biomedical Holdings Co's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Huakang Biomedical Holdings Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where Huakang Biomedical Holdings Co's PB Ratio falls into.



Huakang Biomedical Holdings Co PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Huakang Biomedical Holdings Co's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=0.098/0.133
=0.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Huakang Biomedical Holdings Co  (HKSE:08622) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Huakang Biomedical Holdings Co PB Ratio Related Terms

Thank you for viewing the detailed overview of Huakang Biomedical Holdings Co's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Huakang Biomedical Holdings Co (HKSE:08622) Business Description

Traded in Other Exchanges
N/A
Address
No.16 Yinkui Road, 1-3 floor, Building D, Shenzhen Junxuan, Kui Xin Community, Kui Chong Office, Dapeng New District, Shenzhen, CHN
Huakang Biomedical Holdings Co Ltd is engaged in the research, development, manufacture, marketing, and sale of in-vitro diagnostic reagents and auxiliary reproductive supplies and equipment in China. Its products include Male fertility IVD reagents; Parasite antibody detection reagents; EBV antibody detection reagents; and Auxiliary reproductive supplies and equipment. The group has also diversified its business to vitamins and supplements products for the markets in the PRC, Hong Kong, and overseas.
Executives
Tgga, Llc 2106 Person having a security interest in shares
Lau Lai Yee 2201 Interest of corporation controlled by you
Kokusai Resources Company Limited 2101 Beneficial owner
Zhang Shuguang 2101 Beneficial owner
Crystal Grant Limited 2101 Beneficial owner
Chang Yim Yang 2401 A concert party to an agreement to buy shares
Ever Charming Inc. 2101 Beneficial owner
Wealthy Pride Investment Limited 2101 Beneficial owner

Huakang Biomedical Holdings Co (HKSE:08622) Headlines

No Headlines